Market Survey on Pharmaceutical Drug Delivery Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Pharmaceutical Drug Delivery Market including Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
The global pharmaceutical drug delivery demand is likely to register a CAGR of 6.4%. The market revenue is likely to be valued at US$ 1.9 trillion in 2023 and exhibit a revenue growth of US$ 3.5 trillion by 2033.
Global Trends & Scopes Transforming the Pharmaceutical Drug Delivery Market
Key players strive to improve the results and lives of those suffering from painful and debilitating immune disorders. As a consequence, they have already aided in the transformation of the standard of care for children and adults suffering from psoriatic illness and axial spondylarthritis, chronic urticaria, and several unusual autoinflammatory disorders. They are likely to continue to focus on developing and providing novel medications for complicated, underserved immunological disorders such as hidradenitis suppurativa and Sjögren's syndrome, lupus, and osteoarthritis.
Prominent market players are committed to collaborating with healthcare professionals and healthcare institutions to provide life-changing solutions and treatments. The aim of key players does not cease at altering healthcare through new solutions. It is also based on their contributions to environmental preservation, supply chain sustainability, and social responsibility. They intend to deliver the appropriate therapies to the appropriate patients at the appropriate time. They are better suited to move customized healthcare ahead owing to their combined expertise in drugs and diagnostics. Several key players are at the forefront of collaboration with biotech at various phases of development. This is implemented to attract the use of technology and modality platforms that have the potential to change discovery and develop novel medications that go beyond the standard of care.
They acknowledge that today's complicated healthcare landscape needs innovative and long-term solutions. Furthermore, they must use emerging technology to enhance health systems and achieve the UN Sustainable Development Goals (SDGs), including universal health coverage (UHC). Key players are currently concentrating on building a medical drone delivery system to assure access to critical health items in some of the world's most remote places. This drone delivery system represents a significant advancement for both countries, demonstrating the capacity of public-private collaborations to enhance the effect.
Key companies are also ideally positioned to provide pre-fillable syringe systems for diverse drug regimens, with knowledge in drug container interactions, main container selection, and container/device integration. Additionally, several market participants collaborate with their end consumers to build self-injection systems. This facilitates drug administration over a wide variety of volumes and viscosities by using 'main container technology' and knowledge, with an emphasis on getting products to market quicker. Furthermore, they have successfully partnered their delivery technique with compounds from numerous large pharmaceutical companies.
Attributes
Details
Pharmaceutical Drug Delivery Market HCAGR (2017 to 2022)
9.6%
Pharmaceutical Drug Delivery Market CAGR (2023 to 2033)
6.4%
Market Size for Pharmaceutical Drug Delivery (2023)
US$ 1.9 trillion
Market Size for Pharmaceutical Drug Delivery (2033)
US$ 3.5 trillion
Companies like Evonik (Germany) have made substantial pharmaceutical drug delivery systems investments. For example, it acquired SurModics, specializing in controlled-release parenteral applications. To better compete in this industry, Evonik purchased complementary technologies, including Boehringer Ingelheim's RESOMER platform.
The company also announced WuXi Vaccines in 2019 as a joint venture with Shanghai Hile Bio-Technology Co. WuXi Vaccines is likely to develop specialized pharmaceutical drug delivery systems for the global market. A new class of medicines has emerged in the biopharmaceutical sector, with tremendous potential in cancer, diabetes, and other diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A Contrast with the Historical Market Scenario
The global forum of pharmaceutical drug delivery has undergone outstanding growth in recent years, according to data provided by Future Market Insights. Leading suppliers in the industry are collaborating to meet increased demand for pharmaceutical drug delivery. From 2017 to 2022, the CAGR was 9.6%, and it is predicted to dip to 6.4% over the forecast period.
According to the International Diabetes Federation, the number of people aged 20 to 79 living with diabetes in 2021 was estimated to be over 537 million. According to the same institution, by 2030, this figure is likely to be over 643 million, and by 2045, it is expected to be around 783 million.
The introduction of new technologies is expected to accelerate the growth of the worldwide pharmaceutical medication delivery industry in the coming years. During the forecast period, the worldwide pharmaceutical drug delivery market is expected to be driven by the increasing trend of bringing new pharmaceuticals into the market. During the forecast period, the global pharmaceutical drug delivery market growth is expected to be driven owing to a rise in mergers and acquisitions.
Comparative Analysis of Adjacent Markets
Pharmaceutical Drug Delivery Market:
Attributes
Pharmaceutical Drug Delivery Market
CAGR (2023 to 2033)
6.4%
Market Value (2033)
US$ 3.5 trillion
Growth Factor
Improvement in drug efficacy to improve growth rate.
Opportunity
High investments in R&D activities to offer opportunities.
Key Trends
APAC is the key region to stay invested in.
Drug Discovery Services Market:
Attributes
Drug Discovery Services Market
CAGR (2023 to 2033)
14.5%
Market Value (2033)
US$ 82.6 billion
Growth Factor
Readiness to outsource drug discovery services to support market growth.
Opportunity
Emerging markets in the Asia Pacific hold a high attraction quotient.
Key Trends
Cross-industry collaboration to improve drug efficiency and boost adoption.
Drug Testing Market:
Attributes
Drug Testing Market
CAGR (2023 to 2033)
5%
Market Value (2033)
US$ 38.7 billion
Growth Factor
Government mandates for monitoring and combating substance abuse to augment adoption.
Opportunity
Investment in consumables for the development of advanced products to offer lucrative opportunities.
Key Trends
Demand for innovative testing solutions for opioid to remain high.
Find your sweet spots for generating winning opportunities in this market.
Category-wise Insights
What are the Different Segments in the Pharmaceutical Drug Delivery Market based on Routes of Administration?
Pharmaceutical drugs have been developed to be placed inside the body of patients suffering from several illnesses or supplement the body with essential chemical formulas required by the body. Owing to the ease of intake, the oral drug delivery segment is the most preferred method of administration, having a sizable consumer base. Injectable drug delivery is also commonly used by medical professionals for a large group of pharmaceutical medicines. Both these segments are the main product segments delivered by all pharmaceutical companies.
Ocular and pulmonary drug delivery segments are also important to segment for the pharmaceutical market products. Other than that, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery are emerging segments for drug manufacturing with the development of new treatment methods.
What are the Key Applications of Pharmaceutical Drug Delivery Systems?
The global pharmaceutical drug delivery market can be categorized based on the different applications of its drug. Due to the use of many chemical drugs to treat widespread Infectious diseases around the world, this segment is the key contributor to the revenue generated by biotech and pharmaceutical companies supplying resources for healthcare sectors.
There have been increasing incidences of respiratory diseases, autoimmune diseases, and central nervous system disorders in recent times. Advancement in medical sciences has opened up new avenues for the development of new drugs to control such diseases that are anticipated to boost the business of small generic pharmaceutical companies.
Which are the Leading Facilities Driving the Demand for Pharmaceutical Drug Delivery Systems?
Hospitals and diagnostic centers are the prominent facilities being the leading consumers of the pharmaceutical drug market. There has been a sharp rise in demand for pharmaceutical trade by online platforms for providing drugs for homecare facilities in recent times.
Ambulatory Surgery Centers or local clinics are a few of the new applications of the pharmaceutical drug market experiencing rapid growth due to rising health issues among the population. Therefore, this segment is predicted to hold a higher growth potential during the forecast period, being increasingly targeted by start-up pharmaceutical companies.
What are the Key Pharmaceutical Drug Delivery Market Dynamics?
Increasing investments by prominent market players in pharmaceutical drug delivery systems research and development are driving market expansion.
Firms such as Evonik (Germany) have implemented several strategic initiatives to recognize the potential for biologics production. The firm expanded its manufacturing capacity by purchasing SurModics, a company specializing in controlled-release parenteral applications.
Additionally, Evonik enhanced its competence in this industry by acquiring complementary technologies, such as Boehringer Ingelheim's RESOMER platform. Similarly, WuXi Biologics launched WuXi Vaccines in 2019, a joint venture with Shanghai Hile Bio-Technology Co., Ltd.
The firms formed a strategic alliance under which WuXi Vaccines would establish a specialized facility and offer a commercial product to the worldwide market. The pharmaceutical drug delivery system has seen the introduction of a new class of therapies with tremendous potential for novel cancer, diabetes, and other disease treatments.
What are the Constraints of the Global Market Study on Pharmaceutical Drug Delivery?
Needlestick injuries are one of the greatest threats to an individual's health and safety. Each year, around 600,000 to 800,000 needlestick injuries are reported in the United States, according to PharmaJet. According to OSHA, about 5.6 million employees in the United States of America are at risk of contracting blood-borne diseases as a consequence of needlestick injuries in pharmaceutical drug delivery systems.
Additionally, the CDC estimates that each year manufacturers in the United States struggle with wrong practices of needlestick disposal issues. An average of 385,000 needlestick injuries occur in hospital settings. Similarly, each year in Europe, nearly 1 million needlestick injuries are reported, according to Becton, Dickinson, and Company.
What are the Pharmaceutical Drug Delivery Market Key Trends & Opportunities?
Self-administration and home care are anticipated to present potential prospects for pharmaceutical drug delivery systems. This is mostly attributable to the growing geriatric population since older folks provide a sizable client base for home care drug delivery devices.
This issue also contributes to the increased need for application-specific injectable, inhalation, topical, and transdermal medication treatments that address the demands of caregivers and patients.
How is Pharmaceutical Drug Delivery Market Growth being Seized by Certain Challenges?
Governments in rich and developing nations alike are advocating cost-cutting initiatives such as lowering medication reimbursement rates and boosting the use of generics. Pharmaceutical drug delivery systems worldwide are under enormous cost-cutting pressure from government agencies, insurers, and patients.
This lower pricing pressure results in increased medication acceptance in emerging economies, where there is a considerable need for low-cost treatments. This, however, has a detrimental effect on the profitability of several pharmaceutical drug delivery systems.
This trend is expected to continue in the coming years as insurers, pharmacy benefit managers (PBMs), and public and private payers continue to press for better pharmaceutical dosage forms and drug delivery systems in response to concerns about covering more new medicines to treat prevalent conditions such as high cholesterol and diabetes.
Region-wise Overview
Country
United States
CAGR (2023 to 2033)
6.2%
CAGR (2017 to 2022)
9.2%
Country
United Kingdom
CAGR (2023 to 2033)
5.5%
CAGR (2017 to 2022)
8.3%
Country
China
CAGR (2023 to 2033)
5.8%
CAGR (2017 to 2022)
8.8%
Country
Japan
CAGR (2023 to 2033)
5%
CAGR (2017 to 2022)
7.8%
Country
South Korea
CAGR (2023 to 2033)
4.2%
CAGR (2017 to 2022)
6.4%
Nanotechnology Advancements in the United States have Substantially Enhanced Medication Design
Attributes
Details
United States Market Size (2033)
US$ 1.2 trillion
United States Market Absolute Dollar Growth (US$ million/billion)
US$ 564.6 billion
The United States dominates the pharmaceutical drug delivery industry, accounting for 6.2% of total North American sales. In the United States, the pharmaceutical drug delivery systems market is predicted to reach a high of US$ 1.2 trillion. This is attributed to a rise in the prevalence of chronic illnesses among the United States population. According to one survey, around 60% of the population in the United States suffers from at least one chronic condition, with the majority of them suffering from multiple ailments.
Obesity rates in the United States are rising as a result of fast lifestyle changes, leading to a spate of chronic diseases such as diabetes and heart disease. Nanotechnology advancements have substantially enhanced medication design, allowing for targeted, safe, and efficacious therapeutic compositions incorporating nanoparticles (NP). Nano-drug delivery technologies have shown considerable promise in the country, especially in increasing the solubility of hydrophobic medicines. This improves biodistribution and pharmacokinetics while also providing preferred accumulation at the target location.
Key players specialize in appropriate formulations for medicine release and exposure. Their innovative drug delivery technologies are capable of addressing safety and effectiveness issues discovered during the clinical development of novel molecular entities. They can do so by enhancing their pharmacokinetic and pharmacodynamic characteristics. Furthermore, they can provide pharmaceutical researchers with new ways for surviving patent cliffs. This is accomplished by extending commercial exclusivity when the innovative dosage form meets genuine patient requirements.
Key Players are Developing Drug Delivery Technologies into Valuable Medications for Life-threatening Illnesses
Attributes
Details
United Kingdom Market Size (2033)
US$ 148.1 billion
United Kingdom Market Absolute Dollar Growth (US$ million/billion)
US$ 61.5 billion
With a forecasted value of US$ 148.1 billion and a revenue growth rate of 5.5% throughout the projection period, the United Kingdom is a significant pharmaceutical drug delivery market. Demand for sophisticated medicine delivery systems such as metered-dose inhalers and sensor-embedded devices has increased. Furthermore, the rising prevalence of chronic illnesses is expected to boost market expansion in the area.
Rising cancer, respiratory, and diabetic patients in the country are expected to fuel medication delivery device usage and drive the overall market. According to GLOBOCAN, around 446.94 thousand cancer cases were recorded in the United Kingdom in 2018. The existence of a large target population may necessitate the use of frequent medication delivery devices for diagnosis and treatment, propelling the drug delivery devices market.
The rising frequency of skin disorders in the United Kingdom is also expected to fuel market expansion. According to the Institute for Health Metrics and Evaluation, 22.66 million regional populations had skin infections in 2019. This increased prevalence and improved patient compliance are projected to benefit the industry. Key players are focused to turn developing drug delivery technologies into valuable medications for treating critical and life-threatening illnesses.
Novel Medication Discoveries in China – A Lucrative Region for Key Players!
Attributes
Details
China Market Size (2033)
US$ 252.6 billion
China Market Absolute Dollar Growth (US$ million/billion)
US$ 109.2 billion
China contributes 5.8% of total pharmaceutical drug delivery revenue. The Chinese pharmaceutical drug delivery market is valued at US$ 252.6 billion. The incidence of acute illnesses such as tuberculosis and pneumonia, as well as favorable reimbursement standards for drug delivery manufacturers, are projected to drive market expansion. The rising frequency of chronic illnesses in China has resulted in a rise in the usage of medication delivery devices, notably disposable needles.
According to the International Diabetes Federation's Diabetes Atlas 2021, the age-adjusted comparative prevalence of diabetes in China for 2021 is expected to reach 10.6%, 11.8% in 2030, and 12.5% in 2045. Diabetes incidence is gradually increasing in China, which is likely to enhance demand for prefilled syringes and autoinjectors throughout the forecast period. China is currently faced with the challenge of fostering the expansion of its pharmaceutical sector while providing inexpensive and conveniently available pharmaceuticals for its patient population.
The federal government has taken a top-down strategy in addressing this issue. In 2020, China's healthcare spending as a percentage of GDP was 7.1%. In addition to significant investment, the government has implemented several modifications to the pharmaceutical regulatory environment.
The policy goals established in China's 14th Five-Year Plan and the Healthy China 2030 project each emphasize the importance of healthcare reforms such as eliminating insurance coverage disparities and boosting public services. Furthermore, China's share in the global innovation pipeline has expanded from 4.1 percent in 2015 to 13.9 percent in 2020. This is owing to accelerating novel medication discoveries that have the potential to meet unmet requirements in the local market.
In Japan, Several University Departments Provide Research in the Basic Fields of Organic, Biological & Physical Chemistry
Attributes
Details
Japan Market Size (2033)
US$ 206.4 billion
Japan Market Absolute Dollar Growth (US$ million/billion)
US$ 79.1 billion
With a revenue growth rate of 5% and a predicted value of US$ 206.4 billion during the projection year, Japan is a very profitable pharmaceutical medication delivery industry. Cancer incidence and death have grown in Japan throughout the years. For example, the World Health Organization (WHO) reports that cancer-related mortality in Japan climbed to over 409,400 in 2018. Over the years, the Japanese government has been concerned about the rising death rate.
Increasing malignancies, respiratory ailments, and diabetic patients in Japan are projected to fuel the market for pharmaceutical drug delivery systems. According to the National Cancer Center - Center for Cancer Control and Information Services, the cancer incidence in Japan in 2018 was 1,013,600, with the most prevalent forms of cancer being colorectum, stomach, lung, breast, and prostate cancer. As a result, these factors are projected to propel market expansion throughout the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Newbies are Catching Up with Key Players with Innovative Strategies: Start-up Economy
Start-up companies are offering novel pharmaceutical drug delivery systems with advanced technologies which are expected to contribute to the global pharmaceutical drug delivery market growth:
DrugDeliveryBusiness - It is a business-to-business digital media platform that covers the most recent medical and technological advances in medication transport and delivery systems in the human body. Provides medical technology firms that specialize in transporting and delivering medicinal chemicals to the human body with news, opinions, and technology coverage. As of June 2017, the network of medical theme sites claimed to have 100K+ unique monthly users. Display and banner adverts, as well as sponsored content and lead generation, are used to generate revenue. WTWH Media owns and operates this website.
ForDoz Pharma - It creates drug delivery systems for the treatment of cancers, Parkinson's disease, and drug withdrawal. They have created two drug delivery platforms: NanolipoDoz, a patented phospholipid-based nanotechnology in which pharmacological compounds are designed to improve solubility, and NanolipoDoz Plus. NanopolyDoz is a patented polymer-based nanotechnology platform in which pharmacological ingredients are encased in polymeric matrices that govern medication delivery rates.
Lq3 Pharmaceuticals - It creates oral health solutions that use microparticle and nanoparticle medication delivery methods. Liquidia's unique PRINT technology, which enables the designing and manufacture of accurate microparticle and nanoparticle systems, is used by the firm. Particle size and shape may be modified using this technique to impact medication biodistribution, cellular uptake, intracellular localization, surface deposition, and other product performance factors.
Top Companies Revamping the Pharmaceutical Drug Delivery Market Space
The pharmaceutical drug delivery market share is very competitive owing to the presence of several established rivals. To maximize market growth prospects, these companies are expanding their reach through mergers, developments, product approvals, and launches.
Recent Developments:
In June 2022, for the first time in India, Gufic Biosciences Ltd introduced a revolutionary medication delivery technology, Dual Chamber Bags, at a low cost.
In February 2022, the United States FDA authorized TAKHZYRO (lanadelumab-flyo) injection as a single-dose prefilled syringe (PFS) for the prevention of attacks of hereditary angioedema (HAE) in patients who are at least 12 years of age or older.
In December 2021, Gerresheimer AG has signed a significant deal with American Biotech to develop a novel pump for continuous parenteral delivery of medicine for the treatment of uncommon disorders.
In November 2020, Medtronic introduced the InPen, which is coupled with real-time Guardian Connect CGM data. The tool displays real-time glucose levels as well as insulin dosing information.
Key Market Players
Novartis International AG
F.Hoffmann-La Roche AG
Pfizer Inc.
Becton Dickinson & Company
GlaxoSmithKline PLC
Merck & Co Inc
Sanofi S.A.
Bayer Medicine Products AG
3M
Key Segments Profiled
By Route of Administration:
Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Nasal Drug Delivery
Transmucosal Drug Delivery
Implantable Drug Delivery
By Application:
Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
Others
By Facility of Use:
Hospitals
Ambulatory Surgery Centers/Clinics
Home Care Settings
Diagnostic Centers
Others
By Region:
North America
Latin America
Asia Pacific
The Middle East & Africa
Europe
Frequently Asked Questions
The market is valued at US$ 1.9 trillion in 2023.
The growth potential of the pharmaceutical drug delivery market is 6.4% CAGR through 2033.
The market is estimated to reach US$ 3.5 trillion by 2033.
Upgradations in drug efficacy are positively influencing market growth.
Novartis International AG, F. Hoffmann-La Roche AG, and Pfizer Inc. are key pharmaceutical drug delivery market players.
Table of Content
1. Executive Summary | Pharmaceutical Drug Delivery Marke
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
5.3.1. Oral Drug Delivery
5.3.2. Injectable Drug Delivery
5.3.3. Topical Drug Delivery
5.3.4. Ocular Drug Delivery
5.3.5. Pulmonary Drug Delivery
5.3.6. Nasal Drug Delivery
5.3.7. Transmucosal Drug Delivery
5.3.8. Implantable Drug Delivery
5.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Infectious Diseases
6.3.2. Cancer
6.3.3. Cardiovascular Diseases
6.3.4. Diabetes
6.3.5. Respiratory Diseases
6.3.6. Central Nervous System Disorders
6.3.7. Autoimmune Diseases
6.3.8. Other Applications
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Facility of Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Facility of Use , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Facility of Use , 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgery Centers/Clinics
7.3.3. Home Care Settings
7.3.4. Diagnostic Centers
7.3.5. Other Facilities of Use
7.4. Y-o-Y Growth Trend Analysis By Facility of Use , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Facility of Use , 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Route of Administration
9.2.3. By Application
9.2.4. By Facility of Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Route of Administration
9.3.3. By Application
9.3.4. By Facility of Use
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Route of Administration
10.2.3. By Application
10.2.4. By Facility of Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Route of Administration
10.3.3. By Application
10.3.4. By Facility of
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Route of Administration
11.2.3. By Application
11.2.4. By Facility of
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Route of Administration
11.3.3. By Application
11.3.4. By Facility of
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. India
12.2.1.4. Thailand
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. Rest of Asia Pacific
12.2.2. By Route of Administration
12.2.3. By Application
12.2.4. By Facility of
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Route of Administration
12.3.3. By Application
12.3.4. By Facility of
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Route of Administration
13.2.3. By Application
13.2.4. By Facility of
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Route of Administration
13.3.3. By Application
13.3.4. By Facility of
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Route of Administration
14.1.2.2. By Application
14.1.2.3. By Facility of
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Route of Administration
14.2.2.2. By Application
14.2.2.3. By Facility of
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Route of Administration
14.3.2.2. By Application
14.3.2.3. By Facility of
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Route of Administration
14.4.2.2. By Application
14.4.2.3. By Facility of
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Route of Administration
14.5.2.2. By Application
14.5.2.3. By Facility of
14.6. United kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Route of Administration
14.6.2.2. By Application
14.6.2.3. By Facility of
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Route of Administration
14.7.2.2. By Application
14.7.2.3. By Facility of
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Route of Administration
14.8.2.2. By Application
14.8.2.3. By Facility of
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Route of Administration
14.9.2.2. By Application
14.9.2.3. By Facility of
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Route of Administration
14.10.2.2. By Application
14.10.2.3. By Facility of
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Route of Administration
14.11.2.2. By Application
14.11.2.3. By Facility of
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Route of Administration
14.12.2.2. By Application
14.12.2.3. By Facility of
14.13. Thailand
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Route of Administration
14.13.2.2. By Application
14.13.2.3. By Facility of
14.14. Singapore
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Route of Administration
14.14.2.2. By Application
14.14.2.3. By Facility of
14.15. Australia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Route of Administration
14.15.2.2. By Application
14.15.2.3. By Facility of
14.16. GCC Countries
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Route of Administration
14.16.2.2. By Application
14.16.2.3. By Facility of
14.17. South Africa
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Route of Administration
14.17.2.2. By Application
14.17.2.3. By Facility of
14.18. Israel
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Route of Administration
14.18.2.2. By Application
14.18.2.3. By Facility of
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Route of Administration
15.3.3. By Application
15.3.4. By Facility of
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Johnson & Johnson
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Novartis International AG
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. F. Hoffmann-La Roche AG
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Pfizer Inc
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Becton Dickinson & Company
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Glaxosmithkline PLC
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Merck & Co Inc
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Sanofi
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Bayer AG
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. 3M
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 20: Asia Pacific Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Application, 2017 to 2033
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by Facility of Use , 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 17: Global Market Attractiveness by Route of Administration, 2023 to 2033
Figure 18: Global Market Attractiveness by Application, 2023 to 2033
Figure 19: Global Market Attractiveness by Facility of Use , 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 37: North America Market Attractiveness by Route of Administration, 2023 to 2033
Figure 38: North America Market Attractiveness by Application, 2023 to 2033
Figure 39: North America Market Attractiveness by Facility of Use , 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 57: Latin America Market Attractiveness by Route of Administration, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 59: Latin America Market Attractiveness by Facility of Use , 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 77: Europe Market Attractiveness by Route of Administration, 2023 to 2033
Figure 78: Europe Market Attractiveness by Application, 2023 to 2033
Figure 79: Europe Market Attractiveness by Facility of Use , 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 82: Asia Pacific Market Value (US$ Million) by Application, 2023 to 2033
Figure 83: Asia Pacific Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 97: Asia Pacific Market Attractiveness by Route of Administration, 2023 to 2033
Figure 98: Asia Pacific Market Attractiveness by Application, 2023 to 2033
Figure 99: Asia Pacific Market Attractiveness by Facility of Use , 2023 to 2033
Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 101: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023 to 2033
Figure 102: Middle East and Africa Market Value (US$ Million) by Application, 2023 to 2033
Figure 103: Middle East and Africa Market Value (US$ Million) by Facility of Use , 2023 to 2033
Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033
Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033
Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033
Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Application, 2017 to 2033
Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by Facility of Use , 2017 to 2033
Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by Facility of Use , 2023 to 2033
Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by Facility of Use , 2023 to 2033
Figure 117: Middle East and Africa Market Attractiveness by Route of Administration, 2023 to 2033
Figure 118: Middle East and Africa Market Attractiveness by Application, 2023 to 2033
Figure 119: Middle East and Africa Market Attractiveness by Facility of Use , 2023 to 2033
Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
